ON-DEMAND WEBINARS

Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.

See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

Explore how the new ICH E6 (R3) revisions are reshaping clinical trial oversight and examine how AI-driven tools like the Clinical Decision Suite can help sponsors enhance trial efficiency.

Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor